Pei-Jye Voon

5PUBLICATIONS
52CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Respiratory diseasesSolid tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 06, 2026
ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib.

Zofia Piotrowska, Myung-Ju Ahn, Pei Jye Voon

|Jun 10, 2024
Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study.

Natasha B Leighl, Hiroaki Akamatsu, Sun Min Lim

|May 14, 2024
Hand-foot syndrome in cancer patients on capecitabine: examining prevalence, impacts, and associated risk factors at a cancer centre in Malaysia.

Teck Long King, Pei Jye Voon, Kah Hay Yuen

|Oct 28, 2022
Early phase oncology clinical trials in Malaysia: current status and future perspectives.

Pei-Jye Voon, Wei-Hong Lai, Ros Suzanna Bustaman

|Mar 04, 2021
Health-related quality-of-life assessment of patients with solid tumors on immuno-oncology therapies.

Pei Jye Voon, David Cella, Aaron R Hansen

Pageof 1

Frequent Collaborators

1 joint publications

Aaron R Hansen

1 joint publications

Teck Long King

1 joint publications

Kah Hay Yuen

1 joint publications

Dzul Azri Mohamed Noor